BEGIN:VCALENDAR
CALSCALE:GREGORIAN
METHOD:PUBLISH
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
X-FROM-URL:https://eom.sdu.dk/events/ical/797b0a1c-9fe0-4760-a8d9-77037f7f
 ba56
X-WR-CALNAME:DIAS event: Mikael Palner - Psychedelic drugs: history\, psyc
 hiatry\, and society
BEGIN:VTIMEZONE
TZID:Europe/Copenhagen
X-LIC-LOCATION:Europe/Copenhagen
BEGIN:DAYLIGHT
DTSTAMP:20260510T163633Z
DTSTART:20261028T030000
SEQUENCE:0
TZNAME:CEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
UID:885049f8-714a-4f8c-ad70-1e2ce9a60cb1
END:DAYLIGHT
BEGIN:STANDARD
DTSTAMP:20260510T163633Z
DTSTART:20260325T020000
SEQUENCE:0
TZNAME:CEST
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
UID:9071aabb-c289-4816-8fd7-d6dce4cd7073
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:Associate Professor Mikael Palner from SDU researches the pote
 ntial of psychedelic drugs to treat mental health conditions like anxiety
  and obsessive-compulsive disorder. In this DIAS talk\, Palner will cover
  the history of psychedelic drugs in psychiatry and the clinical evidence
  supporting their effects. He will also explain how these drugs interact 
 with the brain and what decades of recreational use reveal about their sa
 fety. Following this introduction to his field of research\, Palner will 
 join DIAS Chair Christine Stabell Benn for a discussion exploring the cre
 dibility of claims that psychedelics are wonder drugs capable of: \n[list
 ]\n[*]Restoring health in people experiencing illness\n[*]Enhancing healt
 h in people who are already healthy\n[*]Sparking groundbreaking new resea
 rch ideas and insights.\n[/list]\n[b]About Mikael Palner[/b]\n\nMikael Pa
 lner is an Associate Professor at SDU’s Department of Clinical Research a
 nd leads the Neurobiology Research Unit at Copenhagen University Hospital
  (Rigshospitalet). He earned his PhD and master’s degree under Professor 
 Gitte Moos Knudsen\, contributing to the development of 25CN-HBOH\, a hig
 hly selective 5-HT2A agonist\, and the PET tracer 11C-Cimbi-36\, used to 
 evaluate drug occupancy in humans.\n\nPalner completed his postdoc at Sta
 nford University\, focusing on PET imaging in the Molecular Imaging Progr
 am\, working with cancer and brain targets\, including Sigma-1 receptors.
  Back in Denmark\, he established his own research team and heads the pre
 clinical imaging core facility at the University of Southern Denmark. His
  current research involves preclinical functional [18F]FDG PET imaging of
  neuronal circuits and behavioral assessment in rats following neuromodul
 ation and psychedelic drug actions.\n\nMikael Palner is also an active vo
 ice in public discourse on psychiatric diseases and psychedelic drugs.\n\
 n[b][url=https://www.palnerlab.org/publications]Access Mikael Palner's pu
 blications here.[/url][/b]\n\n6 November 2024\nAt the DIAS Auditorium\nOP
 EN FOR ALL
DTEND:20241106T111500Z
DTSTAMP:20260510T163633Z
DTSTART:20241106T101500Z
LOCATION:Danish Institute for Advanced Study\, Fioniavej 34\, 5230\, Odens
 e M
SEQUENCE:0
SUMMARY:DIAS event: Mikael Palner - Psychedelic drugs: history\, psychiatr
 y\, and society
UID:d5e531f9-2695-4dc5-be96-25aa0d1a8b25
END:VEVENT
END:VCALENDAR